1
|
Chaves S, Gwizdała K, Chand K, Gano L, Pallier A, Tóth É, Santos MA. Gd III and Ga III complexes with a new tris-3,4-HOPO ligand as new imaging probes: complex stability, magnetic properties and biodistribution. Dalton Trans 2022; 51:6436-6447. [PMID: 35388858 DOI: 10.1039/d2dt00066k] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
The development of metal-based multimodal imaging probes is a highly challenging field in coordination chemistry. In this context, we have developed a bifunctional hexadentate tripodal ligand (H3L2) with three 3,4-HOPO moieties attached to a flexible tetrahedral carbon bearing a functionalizable nitro group. Complexes formed with different metal ions have potential interest for diagnostic applications, namely magnetic resonance imaging (MRI) and positron emission tomography (PET). The capacity of the ligand to coordinate GdIII and GaIII was studied and the thermodynamic stability constants of the respective complexes were determined by potentiometry and spectrophotometry. The ligand forms stable 1 : 1 ML complexes though with considerably higher affinity for GaIII than for GdIII (pGa = 26.2 and pGd = 14.3 at pH 7). The molecular dynamics simulations of the GdIII complex indicate that two water molecules can coordinate the metal ion, thus providing efficient paramagnetic enhancement of water proton relaxation. The relaxation and the water exchange properties of the GdIII chelate, assessed by a combined 17O NMR and 1H NMRD study, showed associative activated water exchange with a relatively low rate constant, k298ex = (0.82 ± 0.11) × 107 s-1, and some aggregation tendency. Biodistribution studies of the 67Ga-L2 complex suggested good in vivo stability and quick renal clearance. Further anchoring of this ligand with specific biotargeting moieties might open future prospectives for applications of labelled conjugates in both MRI and 68Ga-PET diagnostic imaging.
Collapse
Affiliation(s)
- Silvia Chaves
- Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001, Lisboa, Portugal.
| | - Karolina Gwizdała
- Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001, Lisboa, Portugal. .,Faculty of Chemistry, Gdansk University of Technology, Gabriela Narutowicza 11/12, 80-233 Gdansk, Poland
| | - Karam Chand
- Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001, Lisboa, Portugal.
| | - Lurdes Gano
- Centro de Ciências e Tecnologias Nucleares (C2TN), Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal
| | - Agnès Pallier
- Centre de Biophysique Moléculaire, CNRS UPR 4301, Université d'Orléans, rue Charles Sadron, 45071 Orléans, France.
| | - Éva Tóth
- Centre de Biophysique Moléculaire, CNRS UPR 4301, Université d'Orléans, rue Charles Sadron, 45071 Orléans, France.
| | - M Amélia Santos
- Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001, Lisboa, Portugal.
| |
Collapse
|
2
|
Urriolabeitia A, De Sancho D, López X. Influence of the Nonprotein Amino Acid Mimosine in Peptide Conformational Propensities from Novel Amber Force Field Parameters. J Phys Chem B 2022; 126:2959-2967. [PMID: 35417161 PMCID: PMC9059123 DOI: 10.1021/acs.jpcb.1c09911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
![]()
Mimosine is a nonprotein
amino acid derived from plants known for
its ability to bind to divalent and trivalent metal cations such as
Zn2+, Ni2+, Fe2+, or Al3+. This results in interesting antimicrobial and anticancer properties,
which make mimosine a promising candidate for therapeutic applications.
One possibility is to incorporate mimosine into synthetic short peptide
drugs. However, how this amino acid affects the peptide structure
is not well understood, reducing our ability to design effective therapeutic
compounds. In this work, we used computer simulations to understand
this question. We first built parameters for the mimosine residue
to be used in combination with two classical force fields of the Amber
family. Then, we used atomistic molecular dynamics simulations with
the resulting parameter sets to evaluate the influence of mimosine
in the structural propensities for this amino acid. We compared the
results of these simulations with homologous peptides, where mimosine
is replaced by either phenylalanine or tyrosine. We found that the
strong dipole in mimosine induces a preference for conformations where
the amino acid rings are stacked over more extended conformations.
We validated our results using quantum mechanical calculations, which
provide a robust foundation for the outcome of our classical simulations.
Collapse
Affiliation(s)
- Asier Urriolabeitia
- Department of Physical Chemistry, University of Zaragoza, Calle Pedro Cerbuna, 12, 50009 Zaragoza, Spain
| | - David De Sancho
- Polimero eta Material Aurreratuak: Fisika, Kimika eta Teknologia, Kimika Fakultatea, UPV/EHU & Donostia International Physics Center (DIPC), PK 1072, 20080 Donostia-San Sebastián, Spain
| | - Xabier López
- Polimero eta Material Aurreratuak: Fisika, Kimika eta Teknologia, Kimika Fakultatea, UPV/EHU & Donostia International Physics Center (DIPC), PK 1072, 20080 Donostia-San Sebastián, Spain
| |
Collapse
|
3
|
Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms. Molecules 2022; 27:molecules27061966. [PMID: 35335329 PMCID: PMC8950932 DOI: 10.3390/molecules27061966] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 03/13/2022] [Accepted: 03/14/2022] [Indexed: 01/29/2023] Open
Abstract
Hydroxypyridinones (HPs) are recognized as excellent chemical tools for engineering a diversity of metal chelating agents, with high affinity for hard metal ions, exhibiting a broad range of activities and applications, namely in medical, biological and environmental contexts. They are easily made and functionalizable towards the tuning of their pharmacokinetic properties or the improving of their metal complex thermodynamic stabilities. In this review, an analysis of the recently published works on hydroxypyridinone-based ligands, that have been mostly addressed for environmental applications, namely for remediation of hard metal ion ecotoxicity in living beings and other biological matrices is carried out. In particular, herein the most recent developments in the design of new chelating systems, from bidentate mono-HP to polydentate multi-HP derivatives, with a structural diversity of soluble or solid-supported backbones are outlined. Along with the ligand design, an analysis of the relationship between their structures and activities is presented and discussed, namely associated with the metal affinity and the thermodynamic stability of the corresponding metal complexes.
Collapse
|
4
|
Klahn P, Zscherp R, Jimidar CC. Advances in the Synthesis of Enterobactin, Artificial Analogues, and Enterobactin-Derived Antimicrobial Drug Conjugates and Imaging Tools for Infection Diagnosis. SYNTHESIS-STUTTGART 2022. [DOI: 10.1055/a-1783-0751] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
AbstractIron is an essential growth factor for bacteria, but although highly abundant in nature, its bioavailability during infection in the human host or the environment is limited. Therefore, bacteria produce and secrete siderophores to ensure their supply of iron. The triscatecholate siderophore enterobactin and its glycosylated derivatives, the salmochelins, play a crucial role for iron acquisition in several bacteria. As these compounds can serve as carrier molecules for the design of antimicrobial siderophore drug conjugates as well as siderophore-derived tool compounds for the detection of infections with bacteria, their synthesis and the design of artificial analogues is of interest. In this review, we give an overview on the synthesis of enterobactin, biomimetic as well as totally artificial analogues, and related drug-conjugates covering up to 12/2021.1 Introduction2 Antibiotic Crisis and Sideromycins as Natural Templates for New Antimicrobial Drugs3 Biosynthesis of Enterobactin, Salmochelins, and Microcins4 Total Synthesis of Enterobactin and Salmochelins5 Chemoenzymatic Semi-synthesis of Salmochelins and Microcin E492m Derivatives6 Synthesis of Biomimetic Enterobactin Derivatives with Natural Tris-lactone Backbone7 Synthesis of Artificial Enterobactin Derivatives without Tris-lactone Backbone8 Conclusions
Collapse
Affiliation(s)
- Philipp Klahn
- Institute of Organic Chemistry, Technische Universität Braunschweig
- Department for Chemistry and Molecular Biology, University of Gothenburg
| | - Robert Zscherp
- Institute of Organic Chemistry, Technische Universität Braunschweig
| | | |
Collapse
|
5
|
Sharma S, Baral M, Kanungo BK. Recent advances in therapeutical applications of the versatile hydroxypyridinone chelators. J INCL PHENOM MACRO 2022. [DOI: 10.1007/s10847-021-01114-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
6
|
Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals. Molecules 2021. [DOI: 10.3390/molecules26226997
expr 973886017 + 973118332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
Abstract
Hydroxypyridinones (HOPOs) have been used in the chelation therapy of iron and actinide metals. Their application in metal-based radiopharmaceuticals has also been increasing in recent years. This review article focuses on how multidentate HOPOs can be used in targeted radiometal-based diagnostic and therapeutic radiopharmaceuticals. The general structure of radiometal-based targeted radiopharmaceuticals, a brief description of siderophores, the basic structure and properties of bidentate HOPO, some representative HOPO multidentate chelating agents, radiopharmaceuticals based on HOPO multidentate bifunctional chelators for gallium-68, thorium-227 and zirconium-89, as well as the future prospects of HOPO multidentate bifunctional chelators in other metal-based radiopharmaceuticals are described and discussed in turn. The HOPO metal-based radiopharmaceuticals that have shown good prospects in clinical and preclinical studies are gallium-68, thorium-227 and zirconium-89 radiopharmaceuticals. We expect HOPO multidentate bifunctional chelators to be a very promising platform for building novel targeted radiometal-based diagnostic and therapeutic radiopharmaceuticals.
Collapse
|
7
|
Zhou X, Dong L, Shen L. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals. Molecules 2021; 26:6997. [PMID: 34834087 PMCID: PMC8619595 DOI: 10.3390/molecules26226997&set/a 916769719+956065658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
Abstract
Hydroxypyridinones (HOPOs) have been used in the chelation therapy of iron and actinide metals. Their application in metal-based radiopharmaceuticals has also been increasing in recent years. This review article focuses on how multidentate HOPOs can be used in targeted radiometal-based diagnostic and therapeutic radiopharmaceuticals. The general structure of radiometal-based targeted radiopharmaceuticals, a brief description of siderophores, the basic structure and properties of bidentate HOPO, some representative HOPO multidentate chelating agents, radiopharmaceuticals based on HOPO multidentate bifunctional chelators for gallium-68, thorium-227 and zirconium-89, as well as the future prospects of HOPO multidentate bifunctional chelators in other metal-based radiopharmaceuticals are described and discussed in turn. The HOPO metal-based radiopharmaceuticals that have shown good prospects in clinical and preclinical studies are gallium-68, thorium-227 and zirconium-89 radiopharmaceuticals. We expect HOPO multidentate bifunctional chelators to be a very promising platform for building novel targeted radiometal-based diagnostic and therapeutic radiopharmaceuticals.
Collapse
Affiliation(s)
- Xu Zhou
- HTA Co., Ltd., Beijing 102413, China;
- China Isotope & Radiation Corporation, Beijing 100089, China;
| | - Linlin Dong
- China Isotope & Radiation Corporation, Beijing 100089, China;
| | - Langtao Shen
- HTA Co., Ltd., Beijing 102413, China;
- China Isotope & Radiation Corporation, Beijing 100089, China;
- National Isotope Center of Engineering and Technology, China Institute of Atomic Energy, Beijing 102413, China
- Correspondence:
| |
Collapse
|
8
|
Zhou X, Dong L, Shen L. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals. Molecules 2021; 26:6997. [PMID: 34834087 PMCID: PMC8619595 DOI: 10.3390/molecules26226997] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2021] [Revised: 11/13/2021] [Accepted: 11/17/2021] [Indexed: 01/30/2023] Open
Abstract
Hydroxypyridinones (HOPOs) have been used in the chelation therapy of iron and actinide metals. Their application in metal-based radiopharmaceuticals has also been increasing in recent years. This review article focuses on how multidentate HOPOs can be used in targeted radiometal-based diagnostic and therapeutic radiopharmaceuticals. The general structure of radiometal-based targeted radiopharmaceuticals, a brief description of siderophores, the basic structure and properties of bidentate HOPO, some representative HOPO multidentate chelating agents, radiopharmaceuticals based on HOPO multidentate bifunctional chelators for gallium-68, thorium-227 and zirconium-89, as well as the future prospects of HOPO multidentate bifunctional chelators in other metal-based radiopharmaceuticals are described and discussed in turn. The HOPO metal-based radiopharmaceuticals that have shown good prospects in clinical and preclinical studies are gallium-68, thorium-227 and zirconium-89 radiopharmaceuticals. We expect HOPO multidentate bifunctional chelators to be a very promising platform for building novel targeted radiometal-based diagnostic and therapeutic radiopharmaceuticals.
Collapse
Affiliation(s)
- Xu Zhou
- HTA Co., Ltd., Beijing 102413, China;
- China Isotope & Radiation Corporation, Beijing 100089, China;
| | - Linlin Dong
- China Isotope & Radiation Corporation, Beijing 100089, China;
| | - Langtao Shen
- HTA Co., Ltd., Beijing 102413, China;
- China Isotope & Radiation Corporation, Beijing 100089, China;
- National Isotope Center of Engineering and Technology, China Institute of Atomic Energy, Beijing 102413, China
| |
Collapse
|
9
|
Complexation of environmentally and biologically relevant metals with bifunctional 3-hydroxy-4-pyridinones. J Mol Liq 2020. [DOI: 10.1016/j.molliq.2020.114349] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
10
|
Jiang X, Zhou T, Bai R, Xie Y. Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities. J Med Chem 2020; 63:14470-14501. [PMID: 33023291 DOI: 10.1021/acs.jmedchem.0c01480] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Iron plays an essential role in all living cells because of its unique chemical properties. It is also the most abundant trace element in mammals. However, when iron is present in excess or inappropriately located, it becomes toxic. Excess iron can become involved in free radical formation, resulting in oxidative stress and cellular damage. Iron chelators are used to treat serious pathological disorders associated with systemic iron overload. Hydroxypyridinones stand out for their outstanding chelation properties, including high selectivity for Fe3+ in the biological environment, ease of derivatization, and good biocompatibility. Herein, we overview the potential for multifunctional hydroxypyridinone-based chelators to be used as therapeutic agents against a wide range of diseases associated either with systemic or local elevated iron levels.
Collapse
Affiliation(s)
- Xiaoying Jiang
- Collaborative Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China
| | - Tao Zhou
- School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, P.R. China
| | - Renren Bai
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, P.R. China
| | - Yuanyuan Xie
- Collaborative Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China.,College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, P.R. China
| |
Collapse
|
11
|
Liu X, Dong X, He C, Zhang X, Xiang G, Ma X. New polyazamacrocyclic 3-hydroxy-4-pyridinone based ligands for iron depletion antitumor activity. Bioorg Chem 2020; 96:103574. [DOI: 10.1016/j.bioorg.2020.103574] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2019] [Revised: 01/06/2020] [Accepted: 01/07/2020] [Indexed: 01/05/2023]
|
12
|
Cusnir R, Cakebread A, Cooper MS, Young JD, Blower PJ, Ma MT. The effects of trace metal impurities on Ga-68-radiolabelling with a tris(3-hydroxy-1,6-dimethylpyridin-4-one) (THP) chelator. RSC Adv 2019; 9:37214-37221. [PMID: 35542301 PMCID: PMC9075519 DOI: 10.1039/c9ra07723e] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2019] [Accepted: 10/25/2019] [Indexed: 12/11/2022] Open
Abstract
GMP-grade 68Ge/68Ga generators provide access to positron-emitting 68Ga, enabling preparation of Positron Emission Tomography (PET) tracers and PET imaging at sites that do not have access to cyclotron-produced radionuclides. Radiotracers based on tris(3-hydroxy-1,6-dimethylpyridin-4-one) (THP) chelators enable simple one-step preparations of 68Ga PET radiopharmaceuticals from pre-fabricated kits without pre-processing of generator eluate or post-purification. However, trace metal impurities eluted along with 68Ga could compete for THP and reduce radiochemical yields (RCY). We have quantified trace metal impurities in 68Ga eluate from an Eckert & Ziegler (E&Z) generator using ICP-MS. The metals Al, Fe, natGa, Pb, Ti and natZn were present in generator eluate in significantly higher concentrations than in the starting eluent solution. Concentrations of Fe and natGa in eluate were in the range of 0.01-0.1 μM, Al, Zn and Pb in the range of 0.1-1 μM, and Ti in the range of 0.9-1.5 μM. To assess the ability of THP to chelate 68Ga in the presence of such metal ions, radiolabelling reactions were undertaken in which selected metal ions were added to make them equimolar with THP, or higher. Al3+, Fe3+, natGa3+ and Ti4+ reduced RCY at concentrations equimolar with THP and higher, but at lower concentrations they did not affect RCY. Pb2+, Zn2+, Ni2+ and Cr3+ had no effect on RCY (even under conditions in which each metal ion was present in 100-fold molar excess over THP). The multi-sample ICP-MS analysis reported here is (to date) the most comprehensive and robust quantification of metal impurities in the widely used E&Z 68Ga generator. 68Ga from an E&Z generator enables near-quantitative radiolabelling of THP at chelator concentrations as low as 5 μM (lower than other common gallium chelators) without pre-processing. The combination of Al3+, Fe3+, natGa3+ and Ti4+ in unprocessed 68Ga eluate is likely to decrease RCY of 68Ga radiolabelling if a lower amount of THP chelator is used, and future kit design should take this into account. To increase specific activities by using even lower THP concentrations, purification of 68Ga from trace metal ions will likely be required.
Collapse
Affiliation(s)
- Ruslan Cusnir
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK
- Laboratory of Radiochemistry, Paul Scherrer Institute 5232 Villigen-PSI Switzerland
| | - Andrew Cakebread
- Mass Spectrometry Facility, King's College London Franklin Wilkins Building, 150 Stamford St London SE1 9NH UK
| | - Margaret S Cooper
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK
| | - Jennifer D Young
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK
| | - Philip J Blower
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK
| | - Michelle T Ma
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK
| |
Collapse
|
13
|
Nurchi VM, Cappai R, Chand K, Chaves S, Gano L, Crisponi G, Peana M, Zoroddu MA, Santos MA. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation. Dalton Trans 2019; 48:16167-16183. [PMID: 31577287 DOI: 10.1039/c9dt02905b] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Finding new multifunctional metal binders to be potentially used in diagnosis or therapy has been a subject of major challenge. Hydroxypyridinones have long been recognized as privileged chelating structures for the design of metal chelating drugs, especially towards hard metal ions, in view of their decorporation in metal overload disorders. Thus, pursuing our strategy of engineering new polydentate 3-hydroxy-4-pyridinones (3,4-HP) with extrafunctionalization capacity for sensing or targeting purposes, we report herein the synthesis and full characterization of a hexadentate (tris-3,4-HP) and a tetradentate (bis-3,4-HP) ligand, possessing three and two 3,4-HP arms N-attached to an aminomethanetrispropionic acid backbone, respectively. Thus, as compared with previously reported analogues, each ligand possesses an extra free amino group ready for further functionalization. Their chelating capacity towards Fe and Al was evaluated in aqueous solution, by potentiometric and spectroscopic techniques, and they proved to be strong sequestering agents for these metal ions without depletion of Zn, an essential biometal. Their excellent in vivo metal-decorporation capacity was also evidenced in mice injected with a radiotracer (67Ga) as an animal model of metal overload pathological situations. These findings provide encouragement for further ongoing extrafunctionalizations in view of several potential biomedical applications.
Collapse
Affiliation(s)
- Valeria M Nurchi
- Dipartimento di Scienze della Vita e dell'Ambiente, Università di Cagliari, Cittadella Universitaria, 09042, Monserrato-Cagliari, Italy.
| | - Rosita Cappai
- Dipartimento di Scienze della Vita e dell'Ambiente, Università di Cagliari, Cittadella Universitaria, 09042, Monserrato-Cagliari, Italy. and Centro de Quimica Estrutural, Instituto Superior Tecnico, Universidade de Lisboa, Av, Rovisco Pais 1, 1049-001, Lisboa, Portugal.
| | - Karam Chand
- Centro de Quimica Estrutural, Instituto Superior Tecnico, Universidade de Lisboa, Av, Rovisco Pais 1, 1049-001, Lisboa, Portugal.
| | - Sílvia Chaves
- Centro de Quimica Estrutural, Instituto Superior Tecnico, Universidade de Lisboa, Av, Rovisco Pais 1, 1049-001, Lisboa, Portugal.
| | - Lurdes Gano
- Centro de Ciencias e Tecnologias Nucleares(C2TN), Instituto Superior Tecnico, Universidade de Lisboa, Estrada Nacional 10, 2695-006, Lisboa, Portugal
| | - Guido Crisponi
- Dipartimento di Scienze della Vita e dell'Ambiente, Università di Cagliari, Cittadella Universitaria, 09042, Monserrato-Cagliari, Italy.
| | - Massimiliano Peana
- Dipartimento di Chimica e Farmacia, Università di Sassari, Via Vienna 2, 07100, Sassari, Italy
| | - M Antonietta Zoroddu
- Dipartimento di Chimica e Farmacia, Università di Sassari, Via Vienna 2, 07100, Sassari, Italy
| | - M Amélia Santos
- Centro de Quimica Estrutural, Instituto Superior Tecnico, Universidade de Lisboa, Av, Rovisco Pais 1, 1049-001, Lisboa, Portugal.
| |
Collapse
|
14
|
Mujika JI, Dalla Torre G, Lachowicz JI, Lopez X. In silico design of mimosine containing peptides as new efficient chelators of aluminum. RSC Adv 2019; 9:7688-7697. [PMID: 35521183 PMCID: PMC9061177 DOI: 10.1039/c8ra10139f] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Accepted: 02/26/2019] [Indexed: 12/16/2022] Open
Abstract
The design of new and efficient chelators that can remove aluminium(iii), a metal with increasing recognition as a potential toxic agent, from biological systems is an area of high therapeutic relevance. In the present paper, we present an extensive computational study of a new promising type of these chelators based on mimosine containing peptides. The reason to choose mimosine is that the sidechain of this residue is similar to deferiprone, a ligand known to tightly interact with highly-valent metals, and in particular with Al(iii). In this article we analyze systematically, using a combination of methods that include QM/MM MD simulations, how the size and sequence of the polypeptides can alter the fundamental binding patterns to aluminum, in comparison with the binding to deferiprone. Particular attention is given towards the identification of the smallest peptide that interacts efficiently with aluminum, since polypeptide size is a fundamental factor to allow a given polypeptide to efficiently cross the cell membrane. The results indicate that the longest peptides, with 8 or 9 amino acids, show no difficulties interacting with Al(iii) in an optimum arrangement. By contrast, when the peptide contains five or six amino acids Al(iii) is pentacoordinated, reducing the stability of the resultant complex. In summary, our study demonstrates that the mimosine containing peptides can efficiently coordinate highly valent metals such as Al(iii), with a subtle dependence of the binding on the specific chain-lengths of the polypeptide. We believe that the present study sheds light on the adequacy of this new type of chelator towards aluminum binding. A novel chelator of aluminum is presented, a peptide containing three mimosine residues.![]()
Collapse
Affiliation(s)
- J. I. Mujika
- Kimika Fakultatea
- Euskal Herriko Unibertsitatea UPV/EHU
- Donostia International Physics Center (DIPC)
- 20080 Donostia
- Spain
| | - G. Dalla Torre
- Kimika Fakultatea
- Euskal Herriko Unibertsitatea UPV/EHU
- Donostia International Physics Center (DIPC)
- 20080 Donostia
- Spain
| | - J. I. Lachowicz
- University of Cagliari
- Department of Chemical and Geological Sciences
- Cittadella Universitaria
- Monserrato
- Italy
| | - X. Lopez
- Kimika Fakultatea
- Euskal Herriko Unibertsitatea UPV/EHU
- Donostia International Physics Center (DIPC)
- 20080 Donostia
- Spain
| |
Collapse
|
15
|
New bis-(3-hydroxy-4-pyridinone)-NTA-derivative: Synthesis, binding ability towards Ca2+, Cu2+, Zn2+, Al3+, Fe3+ and biological assays. J Mol Liq 2018. [DOI: 10.1016/j.molliq.2018.09.107] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
16
|
Cilibrizzi A, Abbate V, Chen YL, Ma Y, Zhou T, Hider RC. Hydroxypyridinone Journey into Metal Chelation. Chem Rev 2018; 118:7657-7701. [DOI: 10.1021/acs.chemrev.8b00254] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Agostino Cilibrizzi
- Institute of Pharmaceutical Science, King’s College London, Stamford Street, London SE1 9NH, United Kingdom
| | - Vincenzo Abbate
- Institute of Pharmaceutical Science, King’s College London, Stamford Street, London SE1 9NH, United Kingdom
- King’s Forensics, School of Population Health & Environmental Sciences, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Yu-Lin Chen
- Institute of Pharmaceutical Science, King’s College London, Stamford Street, London SE1 9NH, United Kingdom
| | - Yongmin Ma
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, P. R. China 311402
| | - Tao Zhou
- Department of Applied Chemistry, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, P. R. China 310018
| | - Robert C. Hider
- Institute of Pharmaceutical Science, King’s College London, Stamford Street, London SE1 9NH, United Kingdom
| |
Collapse
|
17
|
Cappai R, Chand K, Lachowicz JI, Chaves S, Gano L, Crisponi G, Nurchi VM, Peana M, Zoroddu MA, Santos MA. A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies. NEW J CHEM 2018. [DOI: 10.1039/c8nj00116b] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A new highly efficient tris-hydroxypyridinone chelator for iron and aluminum, with promising capacity as a potential metal decorporation agent.
Collapse
Affiliation(s)
- Rosita Cappai
- Centro de Química Estrutural
- Instituto Superior Técnico
- Universidade de Lisboa
- 1049-001 Lisboa
- Portugal
| | - Karam Chand
- Centro de Química Estrutural
- Instituto Superior Técnico
- Universidade de Lisboa
- 1049-001 Lisboa
- Portugal
| | - Joanna I. Lachowicz
- Dipartimento di Scienze Chimiche e Geologiche
- Università di Cagliari
- Cittadella Universitaria
- 09042 Monserrato-Cagliari
- Italy
| | - Sílvia Chaves
- Centro de Química Estrutural
- Instituto Superior Técnico
- Universidade de Lisboa
- 1049-001 Lisboa
- Portugal
| | - Lurdes Gano
- Centro de Ciências e Tecnologias Nucleares (C2TN)
- Instituto Superior Técnico
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| | - Guido Crisponi
- Dipartimento di Scienze Chimiche e Geologiche
- Università di Cagliari
- Cittadella Universitaria
- 09042 Monserrato-Cagliari
- Italy
| | - Valeria M. Nurchi
- Dipartimento di Scienze Chimiche e Geologiche
- Università di Cagliari
- Cittadella Universitaria
- 09042 Monserrato-Cagliari
- Italy
| | - Massimiliano Peana
- Dipartimento di Chimica e Farmacia
- Università di Sassari
- 07100 Sassari
- Italy
| | | | - M. Amélia Santos
- Centro de Química Estrutural
- Instituto Superior Técnico
- Universidade de Lisboa
- 1049-001 Lisboa
- Portugal
| |
Collapse
|
18
|
Imberti C, Terry SYA, Cullinane C, Clarke F, Cornish GH, Ramakrishnan NK, Roselt P, Cope AP, Hicks RJ, Blower PJ, Ma MT. Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of α vβ 3 Integrin Expression with Gallium-68. Bioconjug Chem 2017; 28:481-495. [PMID: 27966893 PMCID: PMC5314429 DOI: 10.1021/acs.bioconjchem.6b00621] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2016] [Revised: 11/23/2016] [Indexed: 12/12/2022]
Abstract
Tris(hydroxypyridinone) chelators conjugated to peptides can rapidly complex the positron-emitting isotope gallium-68 (68Ga) under mild conditions, and the resulting radiotracers can delineate peptide receptor expression at sites of diseased tissue in vivo. We have synthesized a dendritic bifunctional chelator containing nine 1,6-dimethyl-3-hydroxypyridin-4-one groups (SCN-HP9) that can coordinate up to three Ga3+ ions. This derivative has been conjugated to a trimeric peptide (RGD3) containing three peptide groups that target the αvβ3 integrin receptor. The resulting dendritic compound, HP9-RGD3, can be radiolabeled in 97% radiochemical yield at a 3-fold higher specific activity than its homologues HP3-RGD and HP3-RGD3 that contain only a single metal binding site. PET scanning and biodistribution studies show that [68Ga(HP9-RGD3)] demonstrates higher receptor-mediated tumor uptake in animals bearing U87MG tumors that overexpress αvβ3 integrin than [68Ga(HP3-RGD)] and [68Ga(HP3-RGD3)]. However, concomitant nontarget organ retention of [68Ga(HP9-RGD3)] results in low tumor to nontarget organ contrast in PET images. On the other hand, the trimeric peptide homologue containing a single tris(hydroxypyridinone) chelator, [68Ga(HP3-RGD3)], clears nontarget organs and exhibits receptor-mediated uptake in mice bearing tumors and in mice with induced rheumatoid arthritis. PET imaging with [68Ga(HP3-RGD3)] enables clear delineation of αvβ3 integrin receptor expression in vivo.
Collapse
Affiliation(s)
- Cinzia Imberti
- King’s College
London, Division of Imaging
Sciences and Biomedical Engineering, Fourth
Floor Lambeth Wing, St Thomas’ Hospital, London SE1 7EH, United Kingdom
| | - Samantha Y. A. Terry
- King’s College
London, Division of Imaging
Sciences and Biomedical Engineering, Fourth
Floor Lambeth Wing, St Thomas’ Hospital, London SE1 7EH, United Kingdom
| | - Carleen Cullinane
- Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Fiona Clarke
- King’s College
London, Academic Department of Rheumatology,
Centre for Molecular and Cellular Biology of Inflammation, Faculty
of Life Sciences and Medicine, London SE1 1UL, United Kingdom
| | - Georgina H. Cornish
- King’s College
London, Academic Department of Rheumatology,
Centre for Molecular and Cellular Biology of Inflammation, Faculty
of Life Sciences and Medicine, London SE1 1UL, United Kingdom
| | - Nisha K. Ramakrishnan
- King’s College
London, Division of Imaging
Sciences and Biomedical Engineering, Fourth
Floor Lambeth Wing, St Thomas’ Hospital, London SE1 7EH, United Kingdom
| | - Peter Roselt
- Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Andrew P. Cope
- King’s College
London, Academic Department of Rheumatology,
Centre for Molecular and Cellular Biology of Inflammation, Faculty
of Life Sciences and Medicine, London SE1 1UL, United Kingdom
| | - Rodney J. Hicks
- Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Philip J. Blower
- King’s College
London, Division of Imaging
Sciences and Biomedical Engineering, Fourth
Floor Lambeth Wing, St Thomas’ Hospital, London SE1 7EH, United Kingdom
| | - Michelle T. Ma
- King’s College
London, Division of Imaging
Sciences and Biomedical Engineering, Fourth
Floor Lambeth Wing, St Thomas’ Hospital, London SE1 7EH, United Kingdom
| |
Collapse
|
19
|
Cusnir R, Imberti C, Hider RC, Blower PJ, Ma MT. Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68. Int J Mol Sci 2017; 18:E116. [PMID: 28075350 PMCID: PMC5297750 DOI: 10.3390/ijms18010116] [Citation(s) in RCA: 45] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Revised: 12/05/2016] [Accepted: 12/21/2016] [Indexed: 01/18/2023] Open
Abstract
Derivatives of 3,4-hydroxypyridinones have been extensively studied for in vivo Fe3+ sequestration. Deferiprone, a 1,2-dimethyl-3,4-hydroxypyridinone, is now routinely used for clinical treatment of iron overload disease. Hexadentate tris(3,4-hydroxypyridinone) ligands (THP) complex Fe3+ at very low iron concentrations, and their high affinities for oxophilic trivalent metal ions have led to their development for new applications as bifunctional chelators for the positron emitting radiometal, 68Ga3+, which is clinically used for molecular imaging in positron emission tomography (PET). THP-peptide bioconjugates rapidly and quantitatively complex 68Ga3+ at ambient temperature, neutral pH and micromolar concentrations of ligand, making them amenable to kit-based radiosynthesis of 68Ga PET radiopharmaceuticals. 68Ga-labelled THP-peptides accumulate at target tissue in vivo, and are excreted largely via a renal pathway, providing high quality PET images.
Collapse
Affiliation(s)
- Ruslan Cusnir
- Division of Imaging Sciences and Biomedical Engineering, King's College London, Fourth Floor Lambeth Wing, St. Thomas' Hospital, London SE1 7EH, UK.
| | - Cinzia Imberti
- Division of Imaging Sciences and Biomedical Engineering, King's College London, Fourth Floor Lambeth Wing, St. Thomas' Hospital, London SE1 7EH, UK.
| | - Robert C Hider
- Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, UK.
| | - Philip J Blower
- Division of Imaging Sciences and Biomedical Engineering, King's College London, Fourth Floor Lambeth Wing, St. Thomas' Hospital, London SE1 7EH, UK.
| | - Michelle T Ma
- Division of Imaging Sciences and Biomedical Engineering, King's College London, Fourth Floor Lambeth Wing, St. Thomas' Hospital, London SE1 7EH, UK.
| |
Collapse
|
20
|
Nurchi VM, Crisponi G, Lachowicz JI, Medici S, Peana M, Zoroddu MA. Chemical features of in use and in progress chelators for iron overload. J Trace Elem Med Biol 2016; 38:10-18. [PMID: 27365273 DOI: 10.1016/j.jtemb.2016.05.010] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Revised: 05/20/2016] [Accepted: 05/30/2016] [Indexed: 01/19/2023]
Abstract
An excessive amount of iron may become extremely toxic both for its ability to generate reactive oxygen species, and for the lack of regulatory mechanisms for iron excretion in humans. Chelation therapy has been introduced in clinical practice in the 1970's to defend thalassemia patients from the effects of iron overload and it has dramatically changed both life expectancy and quality of life. The disadvantages of the drugs in clinical use make the research for new, more suitable iron chelating agents, urgent. This review defines the requirements of an iron chelator, then points out the principal chemical features of the iron chelators in use. Finally, a survey on the last ten years of the literature relative to iron chelators is done, and the most interesting ligands are presented, with particular emphasis to those that reached clinical trials.
Collapse
Affiliation(s)
- Valeria Marina Nurchi
- Department of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria, 09042 Monserrato-Cagliari, Italy.
| | - Guido Crisponi
- Department of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria, 09042 Monserrato-Cagliari, Italy
| | - Joanna I Lachowicz
- Department of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria, 09042 Monserrato-Cagliari, Italy
| | - Serenella Medici
- Department of Chemistry and Pharmacy, University of Sassari, Via Vienna 2, 07100 Sassari, Italy
| | - Massimiliano Peana
- Department of Chemistry and Pharmacy, University of Sassari, Via Vienna 2, 07100 Sassari, Italy
| | | |
Collapse
|
21
|
Spang P, Herrmann C, Roesch F. Bifunctional Gallium-68 Chelators: Past, Present, and Future. Semin Nucl Med 2016; 46:373-94. [DOI: 10.1053/j.semnuclmed.2016.04.003] [Citation(s) in RCA: 60] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
22
|
Jin B, Zheng R, Peng R, Chu S. Synthesis of New Bis(3-hydroxy-4-pyridinone) Ligands as Chelating Agents for Uranyl Complexation. Molecules 2016; 21:299. [PMID: 27005598 PMCID: PMC6273119 DOI: 10.3390/molecules21030299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2016] [Revised: 02/19/2016] [Accepted: 02/23/2016] [Indexed: 11/16/2022] Open
Abstract
Five new bis(3-hydroxy-4-pyridinone) tetradentate chelators were synthesized in this study. The structures of these tetradentate chelators were characterized by ¹H-NMR, (13)C-NMR, FT-IR, UV-vis, and mass spectral analyses. The binding abilities of these tetradentate chelators for uranyl ion at pH 7.4 were also determined by UV spectrophotometry in aqueous media. Results showed that the efficiencies of these chelating agents are dependent on the linker length. Ligand 4b is the best chelator and suitable for further studies.
Collapse
Affiliation(s)
- Bo Jin
- State Key Laboratory Cultivation Base for Nonmetal Composites and Functional Materials, Southwest University of Science and Technology, Mianyang 621010, China.
| | - Rongzong Zheng
- State Key Laboratory Cultivation Base for Nonmetal Composites and Functional Materials, Southwest University of Science and Technology, Mianyang 621010, China.
| | - Rufang Peng
- State Key Laboratory Cultivation Base for Nonmetal Composites and Functional Materials, Southwest University of Science and Technology, Mianyang 621010, China.
| | - Shijin Chu
- State Key Laboratory Cultivation Base for Nonmetal Composites and Functional Materials, Southwest University of Science and Technology, Mianyang 621010, China.
| |
Collapse
|
23
|
3-Hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use. Future Med Chem 2015; 7:383-410. [PMID: 25826364 DOI: 10.4155/fmc.14.162] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Although iron is one of the most important metal ions for living organisms, it becomes toxic when in excess or misplaced. This review presents a glance at representative examples of hydroxypyridinone-based chelators, which have been recently developed as potential clinically useful drugs for metal overload diseases, mostly associated with excess of iron but also other hard metal-ions. It also includes a detailed discussion on the factors assisting chelator design strategy toward fulfillment of the most relevant biochemical properties of hydroxypyridinone chelators, highlighting structure-activity relationships and a variety of potential clinical applications, beyond chelatotherapy. This study appears as a response to the growing interest on metal chelation therapy and opens new perspectives of possible applications in future medicine.
Collapse
|
24
|
Ma MT, Meszaros LK, Paterson BM, Berry DJ, Cooper MS, Ma Y, Hider RC, Blower PJ. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B. Dalton Trans 2015; 44:4884-900. [PMID: 25351250 PMCID: PMC4357251 DOI: 10.1039/c4dt02978j] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2014] [Accepted: 10/17/2014] [Indexed: 01/09/2023]
Abstract
Due to its long half-life (78 h) and decay properties (77% electron capture, 23% β(+), Emax = 897 keV, Eav = 397 keV, Eγ = 909 keV, Iγ = 100%) (89)Zr is an appealing radionuclide for immunoPET imaging with whole IgG antibodies. Derivatives of the siderophore desferrioxamine-B (H3DFO) are the most widely used bifunctional chelators for coordination of (89)Zr(4+) because the radiolabeling of the resulting immunoconjugates is rapid under mild conditions. (89)Zr-DFO complexes are reportedly stable in vitro but there is evidence that (89)Zr(4+) is released in vivo, and subsequently taken up by the skeleton. We have evaluated a novel tripodal tris(hydroxypyridinone) chelator, H3CP256 and its bifunctional maleimide derivative, H3YM103, for coordination of Zr(4+) and compared the NMR spectra, and the (89)Zr(4+) radiolabeling, antibody conjugation, serum stability and in vivo distribution of radiolabelled immunoconjugates with those of H3DFO and its analogues. H3CP256 coordinates (89)Zr(4+) at carrier-free concentrations forming [(89)Zr(CP256)](+). Both H3DFO and H3CP256 were efficiently radiolabelled using [(89)Zr(C2O4)4](4-) at ambient temperature in quantitative yield at pH 6-7 at millimolar concentrations of chelator. Competition experiments demonstrate that (89)Zr(4+) dissociates from [(89)Zr(DFO)](+) in the presence of one equivalent of H3CP256 (relative to H3DFO) at pH 6-7, resulting largely in [(89)Zr(CP256)](+). To assess the stability of H3DFO and H3YM103 immunoconjugates radiolabelled with (89)Zr, maleimide derivatives of the chelators were conjugated to the monoclonal antibody trastuzumab via reduced cysteine side chains. Both immunoconjugates were labelled with (89)Zr(4+) in >98% yield at high specific activities and the labeled immunoconjugates were stable in serum with respect to dissociation of the radiometal. In vivo studies in mice indicate that (89)Zr(4+) dissociates from YM103-trastuzumab with significant amounts of activity becoming associated with bones and joints (25.88 ± 0.58% ID g(-1) 7 days post-injection). In contrast, <8% ID g(-1) of (89)Zr activity becomes associated with bone in animals administered (89)Zr-DFO-trastuzumab over the course of 7 days. The tris(hydroxypyridinone) chelator, H3CP256, coordinates (89)Zr(4+) rapidly under mild conditions, but the (89)Zr-labelled immunoconjugate, (89)Zr-YM103-trastuzumab was observed to release appreciable amounts of (89)Zr(4+)in vivo, demonstrating inferior stability when compared with (89)Zr-DFO-trastuzumab. The significantly lower in vivo stability is likely to be a result of lower kinetic stability of the Zr(4+) tris(hydroxypyridinone complex) relative to that of DFO and its derivatives.
Collapse
Affiliation(s)
- Michelle T. Ma
- King's College London , Division of Imaging Sciences and Biomedical Engineering , 4th Floor Lambeth Wing , St Thomas’ Hospital , London SE1 7EH , UK .
| | - Levente K. Meszaros
- King's College London , Division of Imaging Sciences and Biomedical Engineering , 4th Floor Lambeth Wing , St Thomas’ Hospital , London SE1 7EH , UK .
| | - Brett M. Paterson
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute , The University of Melbourne , Parkville , Victoria 3052 , Australia
| | - David J. Berry
- King's College London , Division of Imaging Sciences and Biomedical Engineering , 4th Floor Lambeth Wing , St Thomas’ Hospital , London SE1 7EH , UK .
| | - Maggie S. Cooper
- King's College London , Division of Imaging Sciences and Biomedical Engineering , 4th Floor Lambeth Wing , St Thomas’ Hospital , London SE1 7EH , UK .
| | - Yongmin Ma
- College of Pharmaceutical Science , Zhejiang Chinese Medical University , Hangzhou , 310053 , People's Republic of China
| | - Robert C. Hider
- King's College London , Institute of Pharmaceutical Science , Franklin Wilkins Building , Stamford St , London SE1 9NH , UK
| | - Philip J. Blower
- King's College London , Division of Imaging Sciences and Biomedical Engineering , 4th Floor Lambeth Wing , St Thomas’ Hospital , London SE1 7EH , UK .
- King's College London , Division of Chemistry , Britannia House , 7 Trinity St , London SE1 1DB , UK
| |
Collapse
|
25
|
Zhou T, Hider RC, Kong X. Mode of iron(iii) chelation by hexadentate hydroxypyridinones. Chem Commun (Camb) 2015; 51:5614-7. [DOI: 10.1039/c4cc10339d] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Tripodal hexadentate hydroxypyridin-4-ones are increasingly utilised as iron(iii) and gallium(iii) ligands, their attachment to proteins being particularly useful for positron emission tomography (PET). A tripodal ligand NTA(BuHP)3, which is reported to form 1 : 1 iron(iii) and gallium(iii) complexes in aqueous, media forms 2 : 2 complexes under physiological conditions.
Collapse
Affiliation(s)
- Tao Zhou
- Department of Applied Chemistry
- School of Food Science and Biotechnology
- Zhejiang Gongshang University
- Hangzhou
- China
| | - Robert C. Hider
- Institute of Pharmaceutical Science
- King's College London
- Franklin-Wilkins Building
- London
- UK
| | - Xiaole Kong
- Institute of Pharmaceutical Science
- King's College London
- Franklin-Wilkins Building
- London
- UK
| |
Collapse
|
26
|
Silva F, Campello MPC, Gano L, Fernandes C, Santos IC, Santos I, Ascenso JR, João Ferreira M, Paulo A. Chemical, radiochemical and biological studies of new gallium(iii) complexes with hexadentate chelators. Dalton Trans 2015; 44:3342-55. [DOI: 10.1039/c4dt02274b] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
New Ga3+ complexes with hexadentate chelators were prepared using natural gallium and radiogallium, and showed some favorable features for radiopharmaceutical research.
Collapse
Affiliation(s)
- Francisco Silva
- Centro de Ciências e Tecnologias e Nucleares
- IST
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| | - Maria Paula C. Campello
- Centro de Ciências e Tecnologias e Nucleares
- IST
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| | - Lurdes Gano
- Centro de Ciências e Tecnologias e Nucleares
- IST
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| | - Célia Fernandes
- Centro de Ciências e Tecnologias e Nucleares
- IST
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| | - Isabel C. Santos
- Centro de Ciências e Tecnologias e Nucleares
- IST
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| | - Isabel Santos
- Centro de Ciências e Tecnologias e Nucleares
- IST
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| | - José R. Ascenso
- Centro de Quimica Estrutural
- IST
- Universidade de Lisboa
- Lisboa
- Portugal
| | - M. João Ferreira
- Centro de Quimica Estrutural
- IST
- Universidade de Lisboa
- Lisboa
- Portugal
| | - António Paulo
- Centro de Ciências e Tecnologias e Nucleares
- IST
- Universidade de Lisboa
- 2695-066 Bobadela LRS
- Portugal
| |
Collapse
|
27
|
Crisponi G, Nurchi VM, Zoroddu MA. Iron Chelating Agents for Iron Overload Diseases. THALASSEMIA REPORTS 2014. [DOI: 10.4081/thal.2014.2046] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
Although iron is an essential element for life, an excessive amount may become extremely toxic both for its ability to generate reactive oxygen species, and for the lack in humans of regulatory mechanisms for iron excretion. Chelation therapy has been introduced in clinical practice in the seventies of last century to defend thalassemic patients from the effects of iron overload and, in spite of all its limitations, it has dramatically changed both life expectancy and quality of life of patients. It has to be considered that the drugs in clinical use present some disadvantages too, this makes urgent new more suitable chelating agents. The requirements of an iron chelator have been better and better defined over the years and in this paper they will be discussed in detail. As a final point the most interesting ligands studied in the last years will be presented.
Collapse
|
28
|
Notni J, Šimeček J, Wester HJ. Phosphinic Acid Functionalized Polyazacycloalkane Chelators for Radiodiagnostics and Radiotherapeutics: Unique Characteristics and Applications. ChemMedChem 2014; 9:1107-15. [DOI: 10.1002/cmdc.201400055] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2014] [Indexed: 11/11/2022]
|
29
|
Chaves S, Capelo A, Areias L, Marques SM, Gano L, Esteves MA, Santos MA. A novel tripodal tris-hydroxypyrimidinone sequestering agent for trivalent hard metal ions: synthesis, complexation and in vivo studies. Dalton Trans 2013; 42:6033-45. [DOI: 10.1039/c2dt32361c] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
30
|
Mendonça AC, Martins AF, Melchior A, Marques SM, Chaves S, Villette S, Petoud S, Zanonato PL, Tolazzi M, Bonnet CS, Tóth É, Di Bernardo P, Geraldes CFGC, Santos MA. New tris-3,4-HOPO lanthanide complexes as potential imaging probes: complex stability and magnetic properties. Dalton Trans 2013; 42:6046-57. [DOI: 10.1039/c2dt32237d] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
31
|
Vacca A, Francesconi O, Roelens S. BC(50): a generalized, unifying affinity descriptor. CHEM REC 2012; 12:544-66. [PMID: 23001996 DOI: 10.1002/tcr.201200014] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2012] [Indexed: 11/10/2022]
Abstract
Assessing binding affinities is an unavoidable step that we come across any time interactions between binding species are investigated. A quantitative evaluation of binding affinities relies on the determination of binding constants but, whilst the binding constant fully defines the affinity of a reagent for a ligand when only one complex species is formed, the same is not true when the interacting partners form more than one complex of different stoichiometry, because all complexes contribute to the overall binding affinity. Unfortunately, this situation is the rule rather than the exception in chemical systems, but a generally accepted solution for this issue has not yet been settled. In this Personal Account, we describe the evolution, from the initial idea to a fully developed stage, of a binding descriptor that has been developed with the aim of filling this gap, thereby providing scientists in all fields of chemistry with a unifying tool for the assessment of binding affinities based on the knowledge of the binding constants in systems that involve any number of complex species.
Collapse
Affiliation(s)
- Alberto Vacca
- Dipartimento di Chimica, Università di Firenze, Polo Scientifico e Tecnologico, I-50019 Sesto Fiorentino, Firenze, Italy
| | | | | |
Collapse
|
32
|
Chaves S, Canário S, Carrasco MP, Mira L, Santos MA. Hydroxy(thio)pyrone and hydroxy(thio)pyridinone iron chelators: Physico-chemical properties and anti-oxidant activity. J Inorg Biochem 2012; 114:38-46. [DOI: 10.1016/j.jinorgbio.2012.04.019] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2011] [Revised: 04/26/2012] [Accepted: 04/26/2012] [Indexed: 10/28/2022]
|
33
|
Bartholomä MD. Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography. Inorganica Chim Acta 2012. [DOI: 10.1016/j.ica.2012.01.061] [Citation(s) in RCA: 96] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Santos MA, Marques SM, Chaves S. Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs. Coord Chem Rev 2012. [DOI: 10.1016/j.ccr.2011.08.008] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
35
|
Bazzicalupi C, Bianchi A, Giorgi C, Clares MP, García-España E. Addressing selectivity criteria in binding equilibria. Coord Chem Rev 2012. [DOI: 10.1016/j.ccr.2011.05.013] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
36
|
Berry DJ, Ma Y, Ballinger JR, Tavaré R, Koers A, Sunassee K, Zhou T, Nawaz S, Mullen GED, Hider RC, Blower PJ. Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands. Chem Commun (Camb) 2011; 47:7068-70. [PMID: 21623436 PMCID: PMC3929899 DOI: 10.1039/c1cc12123e] [Citation(s) in RCA: 107] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
A new tripodal tris(hydroxypyridinone) bifunctional chelator for gallium allows easy production of (68)Ga-labelled proteins rapidly under mild conditions in high yields at exceptionally high specific activity and low concentration.
Collapse
Affiliation(s)
- David J. Berry
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| | - Yongmin Ma
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
- King’s College London, Institute of Pharmaceutical Science, Franklin Wilkins Building, London, SE1 9NH, UK
| | - James R. Ballinger
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| | - Richard Tavaré
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| | - Alexander Koers
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| | - Kavitha Sunassee
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| | - Tao Zhou
- King’s College London, Institute of Pharmaceutical Science, Franklin Wilkins Building, London, SE1 9NH, UK
| | - Saima Nawaz
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| | - Gregory E. D. Mullen
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| | - Robert C. Hider
- King’s College London, Institute of Pharmaceutical Science, Franklin Wilkins Building, London, SE1 9NH, UK
| | - Philip J. Blower
- King’s College London, Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
| |
Collapse
|
37
|
Leite A, Silva AM, Nunes A, Andrade M, Sousa C, Cunha-Silva L, Gameiro P, de Castro B, Rangel M. Novel tetradentate chelators derived from 3-hydroxy-4-pyridinone units: synthesis, characterization and aqueous solution properties. Tetrahedron 2011. [DOI: 10.1016/j.tet.2011.04.035] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
38
|
Crisponi G, Nurchi VM, Faa G, Remelli M. Human diseases related to aluminium overload. MONATSHEFTE FUR CHEMIE 2011. [DOI: 10.1007/s00706-011-0474-x] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
39
|
Chaves S, Mendonça AC, Marques SM, Prata MI, Santos AC, Martins AF, Geraldes CFGC, Santos MA. A gallium complex with a new tripodal tris-hydroxypyridinone for potential nuclear diagnostic imaging: solution and in vivo studies of 67Ga-labeled species. J Inorg Biochem 2010; 105:31-8. [PMID: 21134600 DOI: 10.1016/j.jinorgbio.2010.09.012] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2010] [Revised: 09/27/2010] [Accepted: 09/29/2010] [Indexed: 11/15/2022]
Abstract
The gallium(III) complex of a new tripodal 3-hydroxy-4-pyridinone (3,4-HP) chelator has been studied in terms of its physico-chemical and in vivo properties aimed at potential application as probe for nuclear imaging. In particular, based on spectrophotometric titrations, the hexa-coordinated (1:1) gallium complex appeared as the major species in a wide physiological acid-neutral pH range and its high stability (pGa=27.5) should avoid drug-induced toxicity resulting from Ga(III) accumulation in tissues due to processes of transmetallation with endogenenous ligands or demetallation. A multinuclear ((1)H and (71)Ga) NMR study gave some insights into the structure and dynamics of the gallium(III) chelate in solution, which are consistent with the tris-(3,4-HP) coordination and an eventual pseudo-octahedral geometry. Biodistribution and scintigraphic studies of the (67)Ga(III) labelled chelate, performed in Wistar rats, confirmed the in vivo stability of the radiolabelled complex, its non interaction with blood proteins and its quick renal clearance. These results indicate good perspectives for potential application of extrafunctionalized analogues in radiodiagnostic techniques.
Collapse
Affiliation(s)
- Sílvia Chaves
- Centro de Química Estrutural, Instituto Superior Técnico-UTL, 1049-001 Lisboa, Portugal
| | | | | | | | | | | | | | | |
Collapse
|